IZQVF - Indivior PLC

Other OTC - Other OTC Delayed Price. Currency in USD
0.5170
-0.0110 (-2.08%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.5280
Open0.5190
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4490 - 0.5190
52 Week Range0.3500 - 1.5100
Volume22,602
Avg. Volume22,161
Market Cap371.202M
Beta (5Y Monthly)-0.61
PE Ratio (TTM)2.87
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 15, 2016
1y Target EstN/A
All
News
Press Releases
  • PR Newswire

    Indivior Full Year 2019 Results Now Available; Leadership Presentation Today

    Indivior PLC (LON: INDV) today announced that its full year 2019 press release is now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at www.indivior.com.

  • Virginia Tech and Indivior Announce New Collaboration to Study Long-Term Recovery in People with Opioid Use Disorder
    PR Newswire

    Virginia Tech and Indivior Announce New Collaboration to Study Long-Term Recovery in People with Opioid Use Disorder

    Indivior PLC (LON: INDV) today announced a new research collaboration with Virginia Tech extending the RECOVER (Remission from Chronic Opioid Use-Studying Environmental and Socio-Economic Factors on Recovery) Study ™. RECOVER is a multisite, non-interventional cohort study examining long-term recovery in individuals with moderate to severe opioid use disorder who received at least one dose of study treatment during the SUBLOCADE Phase 3 clinical trials (NCT02357901 and NCT02510014). ¹ The study design and participant characteristics of the RECOVER study can be found in Contemporary Clinical Trials.2 This study will be led by a team of researchers at the Fralin Biomedical Research Institute at Virginia Tech Carilion.